Hims & Hers Health Inc. ($HIMS) Stock Forecast: Up 5.0% Today

What is Hims & Hers Health Inc.?

Hims & Hers Health Inc. (NYSE: HIMS) specializes in telehealth and wellness products, experiencing a notable bullish movement in the market.

Why is Hims & Hers Health Inc. going up?

HIMS stock is up 5.0% on Nov 5, 2024 16:42

• Strong third-quarter results were reported by Hims & Hers Health, surpassing earnings per share expectations at 32 cents.
• The company also revised its full-year revenue forecast upwards, signaling promising growth prospects.
• Bullish options activity by well-funded investors reflects confidence in the company's future performance.
• The favorable earnings report and optimistic market sentiment are key factors likely driving the bullish trend in HIMS stock today.

HIMS Price Chart

HIMS Technical Analysis

HIMS News

What's Going On With Hims & Hers Health Stock Tuesday? - Hims & Hers Health ( NYSE:HIMS )

Hims & Hers Health Inc. HIMS shares are trading higher Tuesday after the company reported strong third-quarter results and raised its full-year revenue outlook. Here's what you need to know. What To Know: Hims & Hers Health reported third-quarter earnings per share of 32 cents, beating estimates ...

https://www.benzinga.com/news/earnings/24/11/41749634/whats-going-on-with-hims-hers-health-stock-tuesday

Hims & Hers Health, Inc. ( HIMS ) Q3 Earnings Match Estimates

Hims & Hers Health (HIMS) delivered earnings and revenue surprises of 0% and 4.52%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2363820/hims-hers-health-inc-hims-q3-earnings-match-estimates

Hims & Hers Health Reports Better-Than-Expected Q3 Results: Details - Hims & Hers Health ( NYSE:HIMS )

Hims & Hers Health, Inc. HIMS reported its third-quarter results after Monday's closing bell. Here's a look at the details from the report. The Details: Hims & Hers Health reported quarterly earnings of 32 cents per share, which beat the analyst consensus estimate of 4 cents.

https://www.benzinga.com/news/earnings/24/11/41728465/hims-hers-health-reports-better-than-expected-q3-results-details

Decoding Hims & Hers Health's Options Activity: What's the Big Picture? - Hims & Hers Health ( NYSE:HIMS )

Deep-pocketed investors have adopted a bullish approach towards Hims & Hers Health HIMS, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.

https://www.benzinga.com/insights/options/24/11/41726551/decoding-hims-hers-healths-options-activity-whats-the-big-picture

What's Going On With Hims & Hers Health Stock Monday? - Hims & Hers Health ( NYSE:HIMS )

Hims & Hers Health HIMS shares are moving higher Monday ahead of earnings after the bell. Here's what you need to know before the report. What To Know: Hims & Hers Health will report third-quarter financial results after the market close on Monday.

https://www.benzinga.com/news/earnings/24/11/41718402/whats-going-on-with-hims-hers-health-stock-monday

Trending Today

dogwifhat ($WIF) Crypto Forecast: Up 6.0% Today

Shiba Inu ($SHIB) Crypto Forecast: Up 7.3% Today

Astera Labs Inc ($ALAB) Stock Forecast: Up 36.0% Today

NXP Semiconductors N.V. ($NXPI) Stock Forecast: Down 7.1% Today

Astrazeneca PLC ($AZN) Stock Forecast: Down 7.1% Today

Avalanche ($AVAX) Crypto Forecast: Up 5.5% Today

Dogecoin ($DOGE) Crypto Forecast: Up 13.1% Today

Bonk ($BONK) Crypto Forecast: Up 9.2% Today

Carvana Co ($CVNA) Stock Forecast: Up 5.2% Today

Vertex Pharmaceuticals Incorporated ($VRTX) Stock Forecast: Up 5.9% Today

Hims & Hers Health Inc. Price History

01.10.2024 - HIMS Stock was up 6.9%

• The third-quarter performance of Hims & Hers Health, Inc. was likely boosted by the increasing adoption of its offerings and the growth of its subscriber base, contributing to the recent bullish movement.
• Although there was a minor -1.1% fluctuation in the stock price in the last trading session, the overall market sentiment remained positive, emphasizing the company's growth potential over this temporary dip.
• Initial concerns may have arisen following an FDA update featuring Novo Nordisk's medications Ozempic and Wegovy, which potentially impacted the stock price briefly. However, investor confidence seems to have been restored since then.
• The bullish movement might also be linked to significant investments in HIMS options by institutional investors and high-net-worth individuals, suggesting a favorable outlook among this demographic.

01.10.2024 - HIMS Stock was up 5.6%

• The stock of HIMS showed strong bullish momentum today, despite a -1.1% change in the closing of the recent trading day.
• An FDA update listing Novo Nordisk's diabetes drug Ozempic and weight-loss drug Wegovy as available potentially influenced some volatility in the stock price.
• Some investors took a bearish stance on HIMS options, possibly leading to market uncertainties, although the general sentiment towards the company remained positive.
• Anticipation of Hims & Hers Health's earnings growth could have contributed to the bullish movement as investors expect favorable financial results in the upcoming period.

30.09.2024 - HIMS Stock was down 16.9%

• Smart money investors have shown bearish sentiments towards HIMS options.
• Earnings expectations for Hims & Hers Health are not very upbeat, reducing the possibility of an earnings beat.
• The bearish options trading and subdued earnings outlook may have led to the significant bearish movement in HIMS stock today.

30.09.2024 - HIMS Stock was down 7.1%

• The bearish movement in HIMS stock today could be attributed to the lack of confidence in the company's upcoming earnings report.
• Investors may be concerned about the company's ability to meet earnings expectations, leading to a sell-off of the stock.
• The market sentiment towards HIMS seems to be cautious due to doubts about the company's potential for a positive earnings surprise.
• It is possible that investors are taking a wait-and-see approach until the earnings report is released before making any significant moves in the stock.

10.09.2024 - HIMS Stock was down 5.5%

• Hims & Hers Health, Inc. (HIMS) witnessed a notable decline despite recent positive developments and optimism from major financial institutions.
• The stock initially saw an uptick in response to expectations of inclusion in the S&P SmallCap 600 this week. However, market sentiment took a turn, leading to the bearish movement.
• Factors such as conflicting signals from earnings estimate changes and overshadowing company news by other market influences likely contributed to the stock's downward trend.
• The bearish movement might also be attributed to traders capitalizing on profits following previous bullish sentiment, particularly after a period of heightened trading activity and scrutiny.

21.09.2024 - HIMS Stock was up 5.3%

• The bullish movement in Hims & Hers Health (HIMS) stock today can be attributed to the significant bullish stance taken by investors with substantial capital, as evidenced by the unusual bullish trades in the options market.
• The confidence shown by financial giants in HIMS, with 62% of traders displaying bullish sentiments, likely contributed to the positive momentum in the stock.
• The FDA's decision to reconsider the removal of Lilly's obesity drug from the shortage list may have also positively influenced investor sentiment in the healthcare sector, indirectly benefiting companies like Hims & Hers Health operating in the telehealth space.

05.10.2024 - HIMS Stock was up 5.0%

• Strong third-quarter results were reported by Hims & Hers Health, surpassing earnings per share expectations at 32 cents.
• The company also revised its full-year revenue forecast upwards, signaling promising growth prospects.
• Bullish options activity by well-funded investors reflects confidence in the company's future performance.
• The favorable earnings report and optimistic market sentiment are key factors likely driving the bullish trend in HIMS stock today.

16.09.2024 - HIMS Stock was up 6.8%

• Strong bullish activity was observed from financial institutions towards Hims & Hers Health, with a majority of traders exhibiting bullish sentiment.
• The FDA reevaluating the ban on drug compounders producing their versions of weight loss medications, which includes products from Hims & Hers Health, was likely a contributing factor to the bullish market movement.
• This regulatory update served as a positive trigger for HIMS stock, leading to a significant increase in its value.
• Amidst general market growth, Hims & Hers Health stock notably outperformed, experiencing a substantial rise attributable to the favorable regulatory news.

15.09.2024 - HIMS Stock was up 10.7%

• HIMS stock rose following the FDA's decision to reconsider the ban on drug compounders selling their versions of weight loss medications, including a popular drug. This decision sparked investor optimism.
• The FDA's decision to permit compounding pharmacies to continue producing certain drugs likely bolstered investor confidence in HIMS's potential for future growth in the health and wellness sector.
• Despite the general market upswing, HIMS stock experienced a significant bullish trend, suggesting that the FDA's regulatory changes had a positive impact on the company's stock performance.

31.09.2024 - HIMS Stock was down 10.7%

• The bearish movement in HIMS stock today could be related to an FDA update mentioning the availability of Novo Nordisk's diabetes drug Ozempic and weight-loss drug Wegovy, which could impact Hims & Hers Health's market share and competitiveness in the health sector.
• The increase in bearish options trading on HIMS suggests that investors with substantial capital have a negative outlook on the stock, possibly due to concerns about the company's future performance or market conditions.
• The lack of positive expectations for Hims & Hers Health's upcoming earnings report may have also influenced the stock price decline, with investors adjusting their positions based on anticipated financial results.

15.09.2024 - HIMS Stock was up 5.4%

• The positive movement in HIMS stock is believed to be linked to recent developments by the U.S. Food and Drug Administration reconsidering its decision, potentially favoring drug compounders such as Hims & Hers Health to market their own versions of well-known weight loss medications.
• This development likely instilled a sense of positivity and confidence among investors in the company's future earnings and expansion prospects, contributing to the stock's upward momentum.
• Amid broader market advances, HIMS stock demonstrated notable strength in its climb, signaling that the specific regulatory news about the FDA's decision played a critical role in propelling the stock's value upward.

23.09.2024 - HIMS Stock was down 5.9%

• Today's downturn in HIMS stock can be linked to these reasons:
• Shift in market sentiment towards bearishness, potentially driven by profit-taking or adverse developments.
• Adjustment in stock price following a notable upswing in the past month and year, impacting the stock's valuation.
• Differing positions held by institutional investors and large stakeholders, fostering uncertainty and influencing the stock downward.
• Reevaluation of the company's price-to-earnings ratio and basic metrics by the market, prompting a reassessment of the stock's value and growth potential.